Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 08/06/20111 min de lecture
Generic Drug User Fee; Notice of Public Meeting; Extension of Comment Period
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is extending the comment period for the notice of public meeting, that appeared in the Federal Register of August 9, 2010 (75 FR 47820). In the notice, FDA requested comments to gather stakeholder input on the development of a generic drug user fee program. The Agency is taking this action to allow interested persons additional time to submit comments.
Langue originale de la source: Federal Register — Health and Human ServicesOuvrir le communiqué original →